SANTEN PHARMACEUTICAL CO., LTD.

Insiders Santen Pharmaceutical Co., Ltd.

Equities

4536

JP3336000009

Delayed Japan Exchange Other stock markets 02:55:10 16/05/2024 BST			5-day change	1st Jan Change
1,590 ^JPY	-1.09%		+3.29%	+13.81%

05-10	Santen Pharmaceutical Intends to Buy Back and Cancel up to 38 Billion Yen Worth of Shares	MT
05-09	Santen Pharmaceutical Co., Ltd. announces an Equity Buyback for 21,110,000 shares, representing 5.81% for ¥38,000 million.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Santen Announces Re-Designation Akira Kurokawa as Director of the Board and Chairman from Representative Director of the Board, Chairman, Effective from April 1, 2024	03-25	CI
Santen Pharmaceutical CEO Resigns, Executive Vice President Takes Over	13/09/22	MT
Santen Pharmaceutical Co., Ltd. Announces CEO Changes	12/09/22	CI
Santen Pharmaceutical Co., Ltd. Announces Management Changes	12/09/22	CI
SanBio Brings in Former Santen Pharmaceutical Department Head as Chief Strategy Officer	02/06/22	MT
Santen Pharmaceutical Co., Ltd. Announces Management Changes, Effective April 1, 2022	23/03/22	CI
Santen Pharmaceutical Co., Ltd. Appoints Tatsuya Kaihara as Corporate Officer and Head of North America Business	01/04/20	CI
Santen Pharmaceutical Co., Ltd. Announces Management Changes, Effective from April 1, 2020	13/03/20	CI
Santen Pharmaceutical Co., Ltd. Announces the Appointment of Corporate Officers, Effective from April 1, 2019	13/03/19	CI
Santen Pharmaceutical Co., Ltd. Appoints Luis Iglesias as Corporate Officer Head of Santen EMEA and Ken Araki as Corporate Officer Head of Global Business Development Department, Effective October 1, 2018	13/09/18	CI
Santen Pharmaceutical Co. Ltd. Announces Management Changes, Effective April 1, 2018	14/03/18	CI
Santen Pharmaceutical Co., Ltd. Announces Executive Changes	20/02/18	CI
Santen Pharmaceutical Co., Ltd. Announces Executive Changes	10/05/17	CI
Santen Pharmaceutical Co., Ltd. Announces Management Appointments, Effective April 1, 2017	15/03/17	CI
Santen Pharmaceutical Co. Ltd. Announces Executive Changes	10/03/16	CI
Santen Pharmaceutical Co Ltd Announces Executive Appointments, Effective April 1, 2015	09/03/15	CI
Santen Pharmaceutical Co. Ltd. Announces Executive Changes	09/03/14	CI
Santen Pharmaceutical Co. Ltd. Announces the Retirement of Toshiaki Nishihata as Director	07/05/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer